Major Depressive Disorder 1402-0011 (Boehringer-Ingelheim)

Clinical trial to examine the efficacy and safety of an investigational medication compound compared to placebo in patients with Major Depressive Disorder.

Qualified participants include:

  • Adults aged 18 to 65 years old
  • Have a diagnosis of major depressive disorder
  • Currently prescribed a study-approved antidepressant (for at least ≥ 8 weeks)

Those that qualify will: 

  • Receive study-related care with a board-certified psychiatrist and other clinical staff at no cost
  • Receive reimbursement for study participant and costs

Contact Clinical Trials at 860.545.7476 or via email

Join our Research Registry

If you are interested in participating in research at the Clinical Trials Unit follow the link below to sign up for our research registry. This will allow us to contact you for current and future research opportunities at the CTU. If you have any questions, please email
 or call 860.545.7476.

Click here to join